{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:07:56Z","timestamp":1740460076385,"version":"3.37.3"},"reference-count":100,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2019,1,25]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>The 2018 European Respiratory Society (ERS) International Congress in Paris, France, highlighted the subject of pulmonary vascular disease (PVD). 2018 was an exciting year for the PVD community as it was the first ERS International Congress since the formation of Assembly 13, which is dedicated to PVD, pulmonary embolism and the right ventricle.<\/jats:p><jats:p>This article aims to summarise the high-quality studies presented at the 2018 Congress into four subject areas: the use of risk stratification in pulmonary arterial hypertension, the molecular mechanisms and treatment of pulmonary hypertension (PH), understanding and improving the right ventricle in PH, and finally, advances in the field of acute pulmonary embolus.<\/jats:p>","DOI":"10.1183\/23120541.00202-2018","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T14:01:11Z","timestamp":1552917671000},"page":"00202-2018","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Highlights from the ERS International Congress 2018: Assembly 13 \u2013 Pulmonary Vascular Diseases"],"prefix":"10.1183","volume":"5","author":[{"given":"Sheila","family":"Ramjug","sequence":"first","affiliation":[]},{"given":"Rui","family":"Ad\u00e3o","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Lewis","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5858-8327","authenticated-orcid":false,"given":"Florence","family":"Coste","sequence":"additional","affiliation":[]},{"given":"Frances","family":"de Man","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-7721","authenticated-orcid":false,"given":"David","family":"Jimenez","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-1951","authenticated-orcid":false,"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-9809","authenticated-orcid":false,"given":"Marion","family":"Delcroix","sequence":"additional","affiliation":[]},{"given":"Anton","family":"Vonk-Noordegraaf","sequence":"additional","affiliation":[]}],"member":"81","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"2024101707171279000_5.1.00202-2018.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"2024101707171279000_5.1.00202-2018.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00072709"},{"key":"2024101707171279000_5.1.00202-2018.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2024101707171279000_5.1.00202-2018.4","first-page":"596","article-title":"A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension","volume":"40","author":"Kylhammar","year":"2017","journal-title":"Eur Heart J"},{"key":"2024101707171279000_5.1.00202-2018.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00740-2017"},{"key":"2024101707171279000_5.1.00202-2018.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00889-2017"},{"key":"2024101707171279000_5.1.00202-2018.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0676"},{"key":"2024101707171279000_5.1.00202-2018.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00497-2018"},{"key":"2024101707171279000_5.1.00202-2018.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA272"},{"key":"2024101707171279000_5.1.00202-2018.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687"},{"key":"2024101707171279000_5.1.00202-2018.11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1753465817696040","article-title":"Ambrisentan: a review of its use in pulmonary arterial hypertension","volume":"11","author":"Rivera-Lebron","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"2024101707171279000_5.1.00202-2018.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA271"},{"key":"2024101707171279000_5.1.00202-2018.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503184"},{"key":"2024101707171279000_5.1.00202-2018.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA268"},{"key":"2024101707171279000_5.1.00202-2018.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA267"},{"key":"2024101707171279000_5.1.00202-2018.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA273"},{"key":"2024101707171279000_5.1.00202-2018.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3113"},{"key":"2024101707171279000_5.1.00202-2018.18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1515PP"},{"key":"2024101707171279000_5.1.00202-2018.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA3277"},{"key":"2024101707171279000_5.1.00202-2018.20","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1111\/bph.13562","article-title":"Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis","volume":"173","author":"Rathinasabapathy","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2024101707171279000_5.1.00202-2018.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1840OC"},{"key":"2024101707171279000_5.1.00202-2018.22","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000296"},{"key":"2024101707171279000_5.1.00202-2018.23","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3389\/fphys.2018.00271","article-title":"rhACE2 therapy modifies bleomycin-induced pulmonary hypertension via rescue of vascular remodeling","volume":"9","author":"Rathinasabapathy","year":"2018","journal-title":"Front Physiol"},{"key":"2024101707171279000_5.1.00202-2018.24","doi-asserted-by":"crossref","first-page":"L249","DOI":"10.1152\/ajplung.00258.2015","article-title":"Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension","volume":"310","author":"Bryant","year":"2016","journal-title":"AJP Lung Cell Mol Physiol"},{"key":"2024101707171279000_5.1.00202-2018.25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA3279"},{"key":"2024101707171279000_5.1.00202-2018.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01857-2017"},{"key":"2024101707171279000_5.1.00202-2018.27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA274"},{"key":"2024101707171279000_5.1.00202-2018.28","doi-asserted-by":"publisher","DOI":"10.3109\/08977194.2014.904300"},{"key":"2024101707171279000_5.1.00202-2018.29","doi-asserted-by":"crossref","first-page":"L965","DOI":"10.1152\/ajplung.00224.2018","article-title":"PDGFBB promotes proliferation and migration via regulating miR-1181\/STAT3 axis in human pulmonary arterial smooth muscle cells","volume":"315","author":"Qian","year":"2018","journal-title":"AJP Lung Cell Mol Physiol"},{"key":"2024101707171279000_5.1.00202-2018.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200707-1037OC"},{"key":"2024101707171279000_5.1.00202-2018.31","first-page":"2811","article-title":"Role of the TGF-\u03b2\/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension","volume":"115","author":"Zaiman","year":"2008","journal-title":"J Clin Invest"},{"key":"2024101707171279000_5.1.00202-2018.32","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0317OC"},{"key":"2024101707171279000_5.1.00202-2018.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200707-1083OC"},{"key":"2024101707171279000_5.1.00202-2018.34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200811-1682OC"},{"key":"2024101707171279000_5.1.00202-2018.35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/679704","article-title":"Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension","volume":"5","author":"Al-Husseini","year":"2015","journal-title":"Pulm Circ"},{"key":"2024101707171279000_5.1.00202-2018.36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1164\/rccm.201410-1851OC","article-title":"Role of nerve growth factor in development and persistence of experimental pulmonary hypertension","volume":"192","author":"Freund-Michel","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101707171279000_5.1.00202-2018.37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112716"},{"key":"2024101707171279000_5.1.00202-2018.38","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA3274"},{"key":"2024101707171279000_5.1.00202-2018.39","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-30"},{"key":"2024101707171279000_5.1.00202-2018.40","doi-asserted-by":"crossref","unstructured":"Weatherald J , Chaumais M-C , Savale L , et al. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. Eur Respir J 2017; 50: 1700217.","DOI":"10.1183\/13993003.00217-2017"},{"key":"2024101707171279000_5.1.00202-2018.41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86249"},{"key":"2024101707171279000_5.1.00202-2018.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.029930"},{"key":"2024101707171279000_5.1.00202-2018.43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3932"},{"key":"2024101707171279000_5.1.00202-2018.44","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.LSC-1044"},{"key":"2024101707171279000_5.1.00202-2018.45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201708-1751OC","article-title":"Mitochondrial HSP90 accumulation promotes vascular remodeling in pulmonary arterial hypertension","volume":"198","author":"Boucherat","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101707171279000_5.1.00202-2018.46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020951"},{"key":"2024101707171279000_5.1.00202-2018.47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/cvr\/cvy016","article-title":"Loss of KCNK3 is a hallmark of RV hypertrophy\/dysfunction associated with pulmonary hypertension","volume":"114","author":"Lambert","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2024101707171279000_5.1.00202-2018.48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MCP.0000000000000404","article-title":"New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways","volume":"23","author":"Huertas","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"2024101707171279000_5.1.00202-2018.49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biocel.2018.08.015","article-title":"Pulmonary arterial hypertension: New pathophysiological insights and emerging therapeutic targets","volume":"104","author":"Bourgeois","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"2024101707171279000_5.1.00202-2018.50","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00805-2017"},{"key":"2024101707171279000_5.1.00202-2018.51","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.healun.2016.04.006","article-title":"Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension","volume":"35","author":"Badagliacca","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2024101707171279000_5.1.00202-2018.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.11.002"},{"key":"2024101707171279000_5.1.00202-2018.53","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA1633"},{"key":"2024101707171279000_5.1.00202-2018.54","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3319"},{"key":"2024101707171279000_5.1.00202-2018.55","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01999-2015"},{"key":"2024101707171279000_5.1.00202-2018.56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA1637"},{"key":"2024101707171279000_5.1.00202-2018.57","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3111"},{"key":"2024101707171279000_5.1.00202-2018.58","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3318"},{"key":"2024101707171279000_5.1.00202-2018.59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccl.2016.04.001","article-title":"World Health Organization group I pulmonary hypertension","volume":"34","author":"Prins","year":"2016","journal-title":"Cardiol Clin"},{"key":"2024101707171279000_5.1.00202-2018.60","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cvr\/cvy076","article-title":"Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension","volume":"114","author":"Ad\u00e3o","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2024101707171279000_5.1.00202-2018.61","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3401"},{"key":"2024101707171279000_5.1.00202-2018.62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA1634"},{"key":"2024101707171279000_5.1.00202-2018.63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/fca-2017-0065","article-title":"Pulmonary hypertension in congenital heart disease","volume":"14","author":"Pascall","year":"2018","journal-title":"Future Cardiol"},{"key":"2024101707171279000_5.1.00202-2018.64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA1638"},{"key":"2024101707171279000_5.1.00202-2018.65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00408-016-9961-5","article-title":"State of the art review of the right ventricle in COPD patients: it is time to look closer","volume":"195","author":"Tannus-Silva","year":"2017","journal-title":"Lung"},{"key":"2024101707171279000_5.1.00202-2018.66","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA1635"},{"key":"2024101707171279000_5.1.00202-2018.67","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA5159"},{"key":"2024101707171279000_5.1.00202-2018.68","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01530-2016"},{"key":"2024101707171279000_5.1.00202-2018.69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.OA1636"},{"key":"2024101707171279000_5.1.00202-2018.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.05.022"},{"key":"2024101707171279000_5.1.00202-2018.71","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200506-862OC"},{"key":"2024101707171279000_5.1.00202-2018.72","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.199"},{"key":"2024101707171279000_5.1.00202-2018.73","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00030412"},{"key":"2024101707171279000_5.1.00202-2018.74","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211539"},{"key":"2024101707171279000_5.1.00202-2018.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00445-2018"},{"key":"2024101707171279000_5.1.00202-2018.76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04388.x"},{"key":"2024101707171279000_5.1.00202-2018.77","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00006114"},{"key":"2024101707171279000_5.1.00202-2018.78","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.thromres.2018.04.002","article-title":"A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism","volume":"165","author":"Bova","year":"2018","journal-title":"Thromb Res"},{"key":"2024101707171279000_5.1.00202-2018.79","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00024-2016"},{"key":"2024101707171279000_5.1.00202-2018.80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11239-015-1284-5","article-title":"Plasma copeptin for short term risk stratification in acute pulmonary embolism","volume":"41","author":"Wyzga\u0142","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"2024101707171279000_5.1.00202-2018.81","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201003-0481OC"},{"key":"2024101707171279000_5.1.00202-2018.82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijcard.2016.11.120","article-title":"Hyponatremia and short-term prognosis of patients with acute pulmonary embolism: a meta-analysis","volume":"227","author":"Zhou","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024101707171279000_5.1.00202-2018.83","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA3120"},{"key":"2024101707171279000_5.1.00202-2018.84","first-page":"330","article-title":"Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the Thrombo-Embolism Lactate Outcome Study","volume":"61","author":"Vanni","year":"2013","journal-title":"YMEM"},{"key":"2024101707171279000_5.1.00202-2018.85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijcard.2018.04.066","article-title":"Risk stratification of acute pulmonary embolism based on clinical parameters, H-FABP and multidetector CT","volume":"265","author":"Dellas","year":"2018","journal-title":"Int J Cardiol"},{"key":"2024101707171279000_5.1.00202-2018.86","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","article-title":"Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2024101707171279000_5.1.00202-2018.87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005544"},{"key":"2024101707171279000_5.1.00202-2018.88","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1358863X16676355","article-title":"Risk factors for major bleeding in the SEATTLE II trial","volume":"22","author":"Sadiq","year":"2017","journal-title":"Vasc Med"},{"key":"2024101707171279000_5.1.00202-2018.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.04.008"},{"key":"2024101707171279000_5.1.00202-2018.90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302097"},{"key":"2024101707171279000_5.1.00202-2018.91","first-page":"1536","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides","year":"2017","journal-title":"JAC"},{"key":"2024101707171279000_5.1.00202-2018.92","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0402"},{"key":"2024101707171279000_5.1.00202-2018.93","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113572"},{"key":"2024101707171279000_5.1.00202-2018.94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302507"},{"key":"2024101707171279000_5.1.00202-2018.95","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"2024101707171279000_5.1.00202-2018.96","doi-asserted-by":"crossref","unstructured":"Mantha S , Laube E , Miao Y , et al. Safe and effective use of rivaroxaban for the treatment of cancer associated venous thromboembolic disease. 2016; 43: 166\u2013171.","DOI":"10.1007\/s11239-016-1429-1"},{"key":"2024101707171279000_5.1.00202-2018.97","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2016.12.168","article-title":"Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight heparin for the prevention of venous thromboembolism in patients with cancer: a meta-analysis study","volume":"230","author":"Brunetti","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024101707171279000_5.1.00202-2018.98","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00040714"},{"key":"2024101707171279000_5.1.00202-2018.99","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00280-2016"},{"key":"2024101707171279000_5.1.00202-2018.100","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12711"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00202-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T04:56:46Z","timestamp":1740373006000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00202-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3,18]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1183\/23120541.00202-2018"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00202-2018","relation":{},"ISSN":["2312-0541"],"issn-type":[{"type":"electronic","value":"2312-0541"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}